Percutaneous left atrial appendage closure – stroke prevention in patients with atrial fibrillation

    Authors

    Keywords

    atrial fibrillation, stroke, prevention

    DOI

    https://doi.org/10.15836/ccar2016.555

    Full Text

    Atrial fibrillation is the most common arrhythmia which affects 1% of general population. Ischemic stroke, as a thromboembolic complication, is 5-7 times more common in patients with nonvalvular atrial fibrillation in relation to general population and affects 23.5% of patients older than 80 years with more severe consequences then in patients with sinus rhythm. (1) Oral anticoagulants, varfarin and novel generation drugs, despite being the standard in treatment are low tolerable or contraindicated in some patients in which percutaneous left atrial appendage closure can be a method of choice in reducing the incidence of ischemic stroke.

    Literature

    1. Pison L, Potpara TS, Chen J, Larsen TB, Bongiorni MG, Blomström-Lundqvist C, Scientific Initiative Committee. European Heart Rhythm Association. Left atrial appendage closure-indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey. Europace. 2015;17(4):642–6. https://doi.org/10.1093/europace/euv069
    Cardiologia Croatica
    Back to search

    Percutaneous left atrial appendage closure – stroke prevention in patients with atrial fibrillation

    Extended Abstract
    Issue10-11
    Published
    Pages555
    PDF via DOIhttps://doi.org/10.15836/ccar2016.555
    atrial fibrillation
    stroke
    prevention

    Authors

    Ana Bognar*ORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Vera ŠilićORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia

    *Correspondence email: ana.bognar@gmail.com

    Full Text

    Atrial fibrillation is the most common arrhythmia which affects 1% of general population. Ischemic stroke, as a thromboembolic complication, is 5-7 times more common in patients with nonvalvular atrial fibrillation in relation to general population and affects 23.5% of patients older than 80 years with more severe consequences then in patients with sinus rhythm. (1)

    Oral anticoagulants, varfarin and novel generation drugs, despite being the standard in treatment are low tolerable or contraindicated in some patients in which percutaneous left atrial appendage closure can be a method of choice in reducing the incidence of ischemic stroke.

    Literature

    1. 1.
      Pison L, Potpara TS, Chen J, Larsen TB, Bongiorni MG, Blomström-Lundqvist C, Scientific Initiative Committee. European Heart Rhythm Association. Left atrial appendage closure-indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey. Europace. 2015;17(4):642–6.DOI